Literature DB >> 35110959

A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic Quinolones.

Sovitj Pou1, Rozalia A Dodean1, Lisa Frueh1, Katherine M Liebman1, Rory T Gallagher2, Haihong Jin3, Robert T Jacobs4, Aaron Nilsen1,3, David R Stuart2, J Stone Doggett1,5, Michael K Riscoe1,6, Rolf W Winter1.   

Abstract

The Endochin-Like Quinolone (ELQ) compound class may yield effective, safe treatments for a range of important human and animal afflictions. However, to access the public health potential of this compound series, a synthetic route needed to be devised that lowers costs and is amenable to large scale production. In the new synthetic route described here, a substituted β-keto ester, formed by an Ullmann reaction and subsequent acylation, is reacted with an aniline via a Conrad-Limpach reaction to produce 3-substituted 4(1H)-quinolones such as ELQ-300 and ELQ-316. This synthetic route, the first described to be truly amenable to industrial scale production, is relatively short (5 reaction steps), does not require palladium, chromatographic separation or protecting group chemistry, and may be performed without high vacuum distillation.

Entities:  

Keywords:  Antimalarial; Conrad-Limpach reaction; ELQ-300; ELQ-316; Ullmann reaction; antiparasitic; practical synthesis; process development

Year:  2021        PMID: 35110959      PMCID: PMC8802981          DOI: 10.1021/acs.oprd.1c00099

Source DB:  PubMed          Journal:  Org Process Res Dev        ISSN: 1083-6160            Impact factor:   3.858


  30 in total

1.  A practical synthesis of indoles via a Pd-catalyzed C-N ring formation.

Authors:  Rishi G Vaswani; Brian K Albrecht; James E Audia; Alexandre Côté; Les A Dakin; Martin Duplessis; Victor S Gehling; Jean-Christophe Harmange; Michael C Hewitt; Yves Leblanc; Christopher G Nasveschuk; Alexander M Taylor
Journal:  Org Lett       Date:  2014-07-28       Impact factor: 6.005

2.  In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum.

Authors:  Joachim Müller; Adriana Aguado; Benoît Laleu; Vreni Balmer; Dominic Ritler; Andrew Hemphill
Journal:  Int J Parasitol       Date:  2017-07-25       Impact factor: 3.981

3.  Metal-free arylation of ethyl acetoacetate with hypervalent diaryliodonium salts: an immediate access to diverse 3-aryl-4(1H)-quinolones.

Authors:  Andrii Monastyrskyi; Niranjan K Namelikonda; Roman Manetsch
Journal:  J Org Chem       Date:  2015-02-24       Impact factor: 4.354

4.  Divergent route to access structurally diverse 4-quinolones via mono or sequential cross-couplings.

Authors:  R Matthew Cross; Roman Manetsch
Journal:  J Org Chem       Date:  2010-11-17       Impact factor: 4.354

5.  Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.

Authors:  Papireddy Kancharla; Rozalia A Dodean; Yuexin Li; Sovitj Pou; Brandon Pybus; Victor Melendez; Lisa Read; Charles E Bane; Brian Vesely; Mara Kreishman-Deitrick; Chad Black; Qigui Li; Richard J Sciotti; Raul Olmeda; Thu-Lan Luong; Heather Gaona; Brittney Potter; Jason Sousa; Sean Marcsisin; Diana Caridha; Lisa Xie; Chau Vuong; Qiang Zeng; Jing Zhang; Ping Zhang; Hsiuling Lin; Kirk Butler; Norma Roncal; Lacy Gaynor-Ohnstad; Susan E Leed; Christina Nolan; Frida G Ceja; Stephanie A Rasmussen; Patrick K Tumwebaze; Philip J Rosenthal; Jianbing Mu; Brett R Bayles; Roland A Cooper; Kevin A Reynolds; Martin J Smilkstein; Michael K Riscoe; Jane X Kelly
Journal:  J Med Chem       Date:  2020-05-26       Impact factor: 7.446

6.  N,N-dimethyl glycine-promoted Ullmann coupling reaction of phenols and aryl halides.

Authors:  Dawei Ma; Qian Cai
Journal:  Org Lett       Date:  2003-10-16       Impact factor: 6.005

7.  Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

Authors:  Chandrakala Pidathala; Richard Amewu; Bénédicte Pacorel; Gemma L Nixon; Peter Gibbons; W David Hong; Suet C Leung; Neil G Berry; Raman Sharma; Paul A Stocks; Abhishek Srivastava; Alison E Shone; Sitthivut Charoensutthivarakul; Lee Taylor; Olivier Berger; Alison Mbekeani; Alasdair Hill; Nicholas E Fisher; Ashley J Warman; Giancarlo A Biagini; Stephen A Ward; Paul M O'Neill
Journal:  J Med Chem       Date:  2012-02-24       Impact factor: 7.446

8.  Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.

Authors:  R Matthew Cross; David L Flanigan; Andrii Monastyrskyi; Alexis N LaCrue; Fabián E Sáenz; Jordany R Maignan; Tina S Mutka; Karen L White; David M Shackleford; Ian Bathurst; Frank R Fronczek; Lukasz Wojtas; Wayne C Guida; Susan A Charman; Jeremy N Burrows; Dennis E Kyle; Roman Manetsch
Journal:  J Med Chem       Date:  2014-10-22       Impact factor: 7.446

9.  Type X strains of Toxoplasma gondii are virulent for southern sea otters (Enhydra lutris nereis) and present in felids from nearby watersheds.

Authors:  Karen Shapiro; Elizabeth VanWormer; Andrea Packham; Erin Dodd; Patricia A Conrad; Melissa Miller
Journal:  Proc Biol Sci       Date:  2019-08-21       Impact factor: 5.349

10.  Activities of Endochin-Like Quinolones Against in vitro Cultured Besnoitia besnoiti Tachyzoites.

Authors:  Naja Eberhard; Vreni Balmer; Joachim Müller; Norbert Müller; Rolf Winter; Soviti Pou; Aaron Nilsen; Mike Riscoe; Samuel Francisco; Alexandre Leitao; J Stone Doggett; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2020-02-26
View more
  2 in total

1.  Iridium-Catalyzed Borylation of 6-Fluoroquinolines: Access to 6-Fluoroquinolones.

Authors:  Aobha Hickey; Julia Merz; Hamad H Al Mamari; Alexandra Friedrich; Todd B Marder; Gerard P McGlacken
Journal:  J Org Chem       Date:  2022-07-15       Impact factor: 4.198

2.  Synthesis and characterization of highly efficient and recoverable Cu@MCM-41-(2-hydroxy-3-propoxypropyl) metformin mesoporous catalyst and its uses in Ullmann type reactions.

Authors:  Zahra S Robatjazi; M Reza Naimi-Jamal; Mahdieh Tajbakhsh
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.